phase 1
ii 1
trial 1
evaluate 1
efficacy 1
fostamatinib 1
patients 2
relapsed 1
refractory 1
diffuse 1
large 1
bcell 1
lymphoma 3
dlbcl 1
transformed 1
nonhodgkin 1
rituximab 1
era 1
analysis 1
nccn 1
outcomes 2
database 1
burkitt 1
older 1
age 1
treated 1
intensive 1
chemotherapeutic 1
regimens 1
